DDX3 (Intermediate Domain) Blocking Peptide

DDX3 (Intermediate Domain) Blocking Peptide

Product No.: D327

[product_table name="All Top" skus="D327"]

- -
- -
Target
DDX3
Product Type
Blocking Peptide
Alternate Names
Dead Box Polypeptide 3 X-Linked, DBX, Helicase-Like Protein 2

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
16 amino acids near the center of human DDX3.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
16 amino acids near the center of human DDX3.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
DDX3 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

References & Citations

1. Liu CY and Kaufman RJ. The unfolded protein response. J. Cell Sci. 2003; 1861-2. 2. Haze K, Yoshida H, Yanagi H, et al. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic stress. Mol. Cell. Biol. 1999; 10:3787-99. 3. Little E, Ramakrishnan M, Roy B, et al. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 1994; 4:1-18. 4. Yoshida H, Matsui T, Yamamoto T, et al. XBP1 mRNA is induced by ATF6 and spliced by IRE1p in response to ER stress to produce a highly active transcription factor. Cell 2001; 107:881-91.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.